Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab), the first and only ... Mar 20, 2025, 12:45 ET Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval ...
pressure can lead to complications like a stroke, a heart attack, kidney disease, vision loss andother health conditions. To help you find a reliable monitor for home use, we consulted cardiologists to find the most accurate and easy-to-use devices available, all of which are FDA-approved....
If approved, Roche will power the launch of ranibizumab PDS with digital health tools, including training modules for clinicians and an app called My Vision Tracker that be used by patients to track changes in sight between treatments, and alert doctors if their vision starts to decline.Image...
Amazon Bestseller Ce FDA BSCI Approved 100% UV400 Double Lens 3D Strap Ski Goggle SNOW-3102 Features 1. Italian-made, wide angle, dual-layer PC lens, Full UV protection, Drop Ball Test compliant. 2. Wide view with great universal fit and s...
When you are buying medicines over the counter or from an approved clinic, you always expect to experience active reactions to make your body feel better. Some of the medication might not have any descriptions of the side effects, but it is believed that they appear to have a more significan...
To learn more about MeMed’s ongoing scientific and clinical studies related to its diagnostic tests, and to access past publications, please visit theMeMed Learning Centeronline. MeMed Severity has not been approved for sale by any regulatory authority. The information pr...
SARATOGA, Calif., July 6 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the U.S. Food and Drug Administration (FDA) has approved the company's Implantable Miniature Telescope (by...
breadth of approved use, side-effect profile and durability of immune response; the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; the timing...
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib; 15 mg, once daily) for...
The Food and Drug Administration (FDA) approved Actos in 1999, Actoplus Met in 2005, Actoplus Met XR in 2009. Duetact in 2006, and Oseni in 2013. Eli Lilly partnered with Takeda to market Actos, and it became one of the most successful diabetes medications of all time. In 2007, it ra...